Find clinical trials for Heart Disease in Boston, MA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Heart Disease trials near Boston, MA, USA:
and will recruit up to 15 patients diagnosed with pulmonary hypertension due to left heart disease that demonstrate combined pre a...
Boston, Massachusetts, United States and 2 other locations
The objective of ENVISION is to evaluate the safety and effectiveness of the Navitor Transcatheter Aortic Valve Implantation (TAVI) System for treati...
Manchester, New Hampshire, United States and 20 other locations
their arms and legs, and have slurred speech. It can also affect the heart and many people with Friedrich Ataxia develop serious heart...
Phase 1
Boston, Massachusetts, United States and 4 other locations
undergo AVR. Clinical indications will be based upon the 2020 AHA/ACC Clinical Practice Guidelines for Valvular Heart Disease.Seco...
Boston, Massachusetts, United States
Prospective, single-arm, multi-center study to evaluate safety and effectiveness of the Autus Size-Adjustable Valve in pediatric patients aged 18 mon...
Boston, Massachusetts, United States and 9 other locations
Safety and performance evaluation of the preCARDIA System for patients with ADHF.
Boston, Massachusetts, United States and 16 other locations
The purpose of this study is to evaluate the device performance and monitor the safety and effectiveness of the Berlin Heart EXCOR Active Dr...
Boston, Massachusetts, United States and 10 other locations
PumpKIN is a multicenter, prospective, single-arm feasibility study; Evaluating the investigational Jarvik 2015 VAD in pediatric patients with heart...
Early Phase 1
Boston, Massachusetts, United States and 6 other locations
This study will evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of PDE5, versus placebo...
Phase 3
Boston, Massachusetts, United States and 26 other locations
Evaluation of the safety and efficacy of the reSept ASD Occluder to treat patients with clinically significant secundum atrial septal defect
Boston, Massachusetts, United States and 27 other locations
Clinical trials
Research sites
Resources
Legal